艾滋病合并卡氏肺孢子菌肺炎20例疗效观察  

作　　者：赵丽惠[1] 杨智彬[1] 曾荣昆[1] 梅光涛[1] 孔庆芬[1] 李阳[1] 杨艳霞[1] 主聪[1] 熊云华[1] 

机构地区：[1]玉溪市人民医院感染科,云南玉溪

出　　处：《中国中医药咨讯》2011年第16期35-36,共2页

摘　　要：目的：探讨艾滋病合并卡氏肺孢子菌肺炎（PCP）的临床特征和治疗方法。方法：回顾性分析20例艾滋病合并PCP患者的临床表现、影像特征及治疗效果等临床资料。结果：该病以发热伴进行性呼吸困难、紫绀等为临床表现，缺乏特异性症状和特征，而影像学改变呈双肺弥漫渗出性病变、肺门、纵隔淋巴结肿大为主还可见局限性渗出性病变、胸腔积液等。结论：结合HIV感染病史，加强对本病的临床表现和影像学知识的认识、及时的诊断性治疗是正确诊断的主要措施。复方新诺明是治疗艾滋病合并卡氏肺孢子菌肺炎安全有效的药物。Objective To discuss the clinical feature and treatment of pneumocystis pneumonia （PCP） in Acquired Immune Deficiency Syndrome （AIDS）.Metheds： Clinical data of 20 patients with PCP in AiDS were analyzed retrospectively including the clinical manifestation, the imaging features and the results.Results： The most significant clinical finding are fever and progressive dyspnea and cyanosis, it is nonspecific. Radiological changes mainly revealed bilateral patchy infiltrates, hilar and mediastinal lymph nodes, and sometimes showed limitation infiltrate and pleural effusion and so on.Conclusion： The main exact diagnosis measure is to synthesise the history of HIV infection, the clinical manifestations, radiologicsl changes and timely diagnostic therapy. SMZ-TMP is the safe and effective drug treatments for PCP in AIDS.

关 键 词：艾滋病 卡氏肺孢子菌肺炎 复方新诺明 

分 类 号：R512.91[医药卫生—内科学]